Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -23.079% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) Cc1ccc(S[C@@H](CCN2CC[C@H](O)CCC2=O)c2ccccc2)cc1
b) COCCNC(=O)c1cccc(OC2CCN(Cc3ccc(F)cc3OC)CC2)c1
Answer: b. COCCNC(=O)c1cccc(OC2CCN(Cc3ccc(F)cc3OC)CC2)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCNC(=O)c1cccc(OC2CCN(Cc3ccc(F)cc3OC)CC2)c1
COCCNC(=O)c1cccc(OC2CCN(Cc3ccc(F)cc3OC)CC2)c1
3-[1-[(4-fluoro-2-methoxyphenyl)methyl]piperidin-4-yl]oxy-N-(2-methoxyethyl)benzamide